Functional MRC With Eovist for Acute Cholecystitis (MRC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02100358|
Recruitment Status : Completed
First Posted : March 31, 2014
Last Update Posted : May 30, 2017
|Condition or disease|
To determine the accuracy of fMRC in evaluating patients with suspected cholecystitis.
To compare the results of fMRC with conventional hepatobiliary scintigraphy.
|Study Type :||Observational|
|Actual Enrollment :||17 participants|
|Official Title:||Accuracy of Functional MRC With Gadoxetate Disodium in the Diagnosis of Acute Cholecystitis: Comparison With Hepatobiliary Scintigraphy|
|Study Start Date :||February 2013|
|Actual Primary Completion Date :||April 2016|
|Actual Study Completion Date :||April 2016|
- Number of positive cases of acute cholecystitis [ Time Frame: 2 years ]The primary outcome measure is the number of positive cases of acute cholecystitis on functional magnetic resonance imaging
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02100358
|United States, California|
|UC Davis Medical Center|
|Sacramento, California, United States, 95817|
|Principal Investigator:||Michael T Corwin, MD||Assistant Professor|